VAUDREUIL-DORION, QUEBEC--(Marketwired - March 6, 2014) - Immunotec Inc. (TSX VENTURE:IMM), a Canadian based company and a leader in the wellness industry (the "Company") today announced that Mr. Daniel Audet, Vice-President, Marketing, will be leaving Immunotec effective March 11, 2014 to pursue new opportunities.
To enable smooth operational functioning and an orderly evaluation of organizational needs, Ms. Kim Hayes will serve as Senior Director of Marketing with accountability for all marketing functions. Ms. Hayes will report to JP Trottier, Vice-President of Field Development.
"Over the past three years, Mr. Audet and his team have made significant contributions to advancing Immunotec's performance and it is with appreciation that we wish all the best to Daniel in his future endeavors", said Mr. Charles L. Orr, Chief Executive Officer. "Ms. Hayes, as Director of Programs and Recognition, had the lead responsibility for delivering the 2014 Convention in Santa Fe, Mexico, 2013 Incentive Trip and 2013 Barbecue, all highly successful activities. Ms. Hayes is a strong, knowledgeable leader and I am certain that she will be able to make an immediate positive impact on Immunotec's marketing activities."
About Immunotec Inc.
Immunotec Inc. is dedicated to making a positive difference in people's lifestyle every day by offering research-driven nutritional products through its network of Independent Consultants worldwide. Immunotec's strength comes from its culture that emphasizes teamwork and entrepreneurial leadership by employees, consultants and research collaborators.
Headquartered with manufacturing facilities near Montreal, Canada, Immunotec Consultants generate nearly $55.0 Million in annual revenues. Please visit us at www.immunotec.com for additional information.
The Company files its consolidated financial statements, its management and discussion analysis report, its press releases and such other required documents on the SEDAR database at www.sedar.com and on the Company's website at www.immunotec.com. The common shares of the Company are listed on the TSX Venture Exchange under the ticker symbol IMM. Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
CAUTION REGARDING FORWARD-LOOKING STATEMENTS: Certain statements contained in this news release are forward looking and are subject to numerous risks and uncertainties, known and unknown. For information identifying known risks and uncertainties and other important factors that could cause actual results to differ materially from those anticipated in the forward-looking statements, please refer to the heading Risks and Uncertainties in Immunotec's most recent Management's Discussion and Analysis, which can be found at www.sedar.com. Consequently, actual results may differ materially from the anticipated results expressed in these forward-looking statements.